Once in use, observe the specified in-use period and allow a refrigerated pen to reach ambient laboratory temperature before use
"The more weight you lose, [the more] it creates other risks for you," Fitch said.
Pharma Industry 3 min read WHO backs GLP-1 treatments to tackle obesity epidemic On Monday, the United Nations health agency issued its first guidelines on how such drugs could be used as a key tool for treating obesity in adults as a chronic, relapsing disease
Researchers are now taking a closer look at these other potential indications for GLP-1 agonists
Importantly, no serious adverse events have been documented in over 100 preclinical studies (Sikiric et al., 2016)
If your exercise intensity increases, your nutritional and medicinal needs change